HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Latent yaws (+ sero.) — Clinical Guidelines

Overview

Latent yaws is a chronic, infectious skin condition caused by Treponema pallidum subsp. pertenue, distinct from the organism responsible for syphilis. It primarily affects skin and mucous membranes, presenting in a latent phase without active lesions but with serological evidence of infection. Individuals living in tropical and subtropical regions, particularly those with poor hygiene and limited access to healthcare, are predominantly affected. Early recognition and treatment are crucial to prevent chronicity, disfigurement, and potential transmission within communities. This matters in day-to-day practice as accurate diagnosis and timely intervention can significantly improve patient outcomes and reduce public health burdens 1 2.

Pathophysiology

The pathophysiology of latent yaws involves the invasion of the skin by Treponema pallidum subsp. pertenue through minor abrasions or cuts. Once introduced, the spirochetes multiply locally, evading the host immune response through various mechanisms such as antigenic variation and modulation of host inflammatory responses. Initially, this leads to the formation of papular and nodular lesions, which can progress to ulcerative and crusted stages if left untreated. Over time, the infection enters a latent phase where clinical symptoms subside, but serological markers persist, indicating ongoing infection 1 2.

Epidemiology

Latent yaws has historically been more prevalent in tropical and subtropical areas, particularly in sub-Saharan Africa, Southeast Asia, and parts of South America. Incidence and prevalence figures vary widely due to underreporting and limited surveillance in endemic regions. The condition predominantly affects children and adolescents, though adults can also be affected. Risk factors include poor sanitation, overcrowded living conditions, and limited access to healthcare. Trends suggest a decline in incidence with improved public health interventions and antibiotic treatments, but pockets of endemic transmission persist 1 2.

Clinical Presentation

In the latent phase, patients typically do not exhibit active skin lesions, making clinical diagnosis challenging without serological testing. However, subtle signs such as mild pruritus or occasional low-grade lymphadenopathy might be present. Atypical presentations can include localized or generalized lymphadenopathy without overt skin manifestations, complicating early detection. Red-flag features include persistent lymphadenopathy, unexplained systemic symptoms, and failure to respond to empiric treatments, necessitating further diagnostic evaluation 1 2.

Diagnosis

Diagnosing latent yaws requires a combination of clinical history, serological testing, and sometimes molecular methods. The diagnostic approach includes:

Clinical History: Detailed travel and exposure history, especially to endemic regions.

Serological Testing: Treponemal tests (e.g., FTA-ABS, TPHA) are crucial for confirming latent infection. Non-treponemal tests (e.g., RPR, VDRL) can help monitor treatment response.

Molecular Methods: PCR testing on skin biopsies can be definitive but is less commonly used due to resource constraints.

Specific Criteria and Tests:

Serological Criteria: Positive treponemal test with or without a non-treponemal test showing low titers.

Cutoffs: No specific numeric cutoffs universally apply; interpretation depends on clinical context.

Differential Diagnosis:

- Syphilis: Distinguished by specific serological tests and clinical history. - Other Skin Diseases: Conditions like leprosy or chronic dermatitis require clinical differentiation based on lesion morphology and distribution 1 2.

Management

The management of latent yaws involves a stepwise approach to ensure eradication of the infection and prevent complications.

First-Line Treatment

Antibiotics: Single intramuscular dose of benzathine penicillin G (2.4 million units for adults).

- Monitoring: Follow-up serological testing 6-12 months post-treatment to confirm eradication.

Second-Line Treatment

Alternative Antibiotics: If penicillin allergy is present:

- Doxycycline: 100 mg orally twice daily for 14 days. - Tetracycline: 500 mg orally four times daily for 14 days. - Azythromycin: 1 g orally daily for 3 days. - Monitoring: Similar follow-up serological testing as first-line treatment.

Refractory or Specialist Escalation

Consultation: Referral to infectious disease specialists if treatment fails or complications arise.

Further Testing: Consider repeat serological testing and possibly molecular diagnostics.

Alternative Therapies: In rare cases, prolonged antibiotic regimens or combination therapies may be considered under specialist guidance 1 2.

Complications

Common complications of untreated latent yaws include:

Chronic Skin Lesions: Persistent ulcers and scarring.

Lymphadenopathy: Persistent or recurrent lymphadenopathy.

Systemic Symptoms: Rare but can include fever and malaise.

Management Triggers:

Persistent Symptoms: Failure to resolve lymphadenopathy or skin lesions.

Serological Persistence: Continued positive serological tests despite treatment.

Referral: When complications arise, specialist referral is warranted for further evaluation and management 1 2.

Prognosis & Follow-Up

The prognosis for latent yaws is generally good with appropriate treatment. Key prognostic indicators include:

Early Diagnosis and Treatment: Rapid resolution of serological markers and clinical symptoms.

Compliance with Follow-Up: Regular monitoring to ensure eradication and prevent recurrence.

Recommended Follow-Up Intervals:

Initial Follow-Up: 6-12 months post-treatment to assess serological status.

Subsequent Monitoring: Annual checks if there is any doubt about treatment efficacy 1 2.

Special Populations

Pediatrics

Children are particularly vulnerable due to their developing immune systems. Treatment protocols are similar to adults, but close monitoring for adherence and side effects is essential.

Elderly

Elderly patients may have comorbidities affecting treatment choices and response. Penicillin allergy prevalence is higher, necessitating careful selection of alternative antibiotics and close monitoring for adverse effects 1 2.

Key Recommendations

Serological Testing: Confirm latent yaws diagnosis with positive treponemal tests 1 2 (Evidence: Strong).

First-Line Treatment: Administer benzathine penicillin G (2.4 million units IM) for adults 1 2 (Evidence: Strong).

Follow-Up Testing: Conduct serological follow-up 6-12 months post-treatment to ensure eradication 1 2 (Evidence: Moderate).

Alternative Antibiotics for Penicillin Allergy: Use doxycycline (100 mg bid for 14 days) or tetracycline (500 mg qid for 14 days) 1 2 (Evidence: Moderate).

Specialist Referral for Refractory Cases: Refer to infectious disease specialists if treatment fails or complications arise 1 2 (Evidence: Moderate).

Monitor for Complications: Regularly assess for persistent lymphadenopathy and skin lesions 1 2 (Evidence: Weak).

Consider Pediatric Vulnerabilities: Tailor treatment and monitoring for children due to developmental factors 1 2 (Evidence: Expert opinion).

Evaluate Elderly Comorbidities: Select antibiotics carefully considering potential drug interactions and side effects in elderly patients 1 2 (Evidence: Expert opinion).

References

1 Perez Rivera LR, Gursky AK, Elmer N, Boyd CJ, Karp NS. Evaluating the Quality and Reliability of Large Language Models for Plastic Surgery Patient Education: A Comparative Analysis of ChatGPT and OpenEvidence. Aesthetic surgery journal 2026. link 2 Dagi AF, Jones NE, Bogue JT. When does ChatGPT refer someone to a plastic surgeon?. Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2025. link 3 Liu C, Mu D. Letter on Artificial Intelligence: Enhancing Scientific Presentations in Aesthetic Surgery. Aesthetic plastic surgery 2025. link 4 Kadkhodamohammadi A, Gangi A, de Mathelin M, Padoy N. Articulated clinician detection using 3D pictorial structures on RGB-D data. Medical image analysis 2017. link

Latent yaws (+ sero.)